Sort   by:  
 Page size 
UnknownAtezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.
Not available
S-EPMC6886121 | biostudies-literature
UnknownTracheal Intubation by Advanced Practice Registered Nurses in Pediatric Critical Care: Retrospective Study From the National Emergency Airway for Children Registry (2015-2019).
Not available
S-EPMC10842935 | biostudies-literature
UnknownDownward Trend in Pediatric Resident Laryngoscopy Participation in PICUs.
Not available
S-EPMC5935530 | biostudies-literature
UnknownRelationship Between Adverse Tracheal Intubation Associated Events and PICU Outcomes.
Not available
S-EPMC5554859 | biostudies-literature
UnknownPertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
Not available
S-EPMC5705202 | biostudies-literature
UnknownAdverse Tracheal Intubation Events in Critically Ill Underweight and Obese Children: Retrospective Study of the National Emergency Airway for Children Registry (2013-2020).
Not available
S-EPMC10841296 | biostudies-literature
UnknownPertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.
Not available
S-EPMC5584549 | biostudies-literature
UnknownAdjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
Not available
S-EPMC5538020 | biostudies-literature
UnknownOverall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Not available
S-EPMC10207856 | biostudies-literature
UnknownAdjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer.
Not available
S-EPMC9126186 | biostudies-literature
Sort   by:  
 Page size